Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N4CD | ISIN: AU0000021461 | Ticker-Symbol: 9CH
Tradegate
13.02.26 | 20:20
0,191 Euro
-4,50 % -0,009
Branche
Rohstoffe
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
GALAN LITHIUM LIMITED Chart 1 Jahr
5-Tage-Chart
GALAN LITHIUM LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
0,1950,20214.02.
0,1900,21013.02.
ACCESS Newswire
387 Leser
Artikel bewerten:
(2)

Galan Lithium Limited: A$40 Million Institutional Placement to Support 30% Expansion of Phase 1 Hombre Muerto West

Highlights:

  • Galan has received firm commitments to raise A$40 million (before costs) via an institutional placement at A$0.41 per share, a 2% premium to the 5-day VWAP

  • Directors of the Company have separately committed to subscribe for an additional A$1 million subject to shareholder approval

  • Placement was strongly supported by existing substantial shareholder Clean Elements as well as global institutional and sophisticated investors

  • Proceeds of the capital raising will be used to expand production at HMW from current planned 4 ktpa LCE to 5.2 ktpa LCE, fund exploration activities at Greenbushes South and for working capital

  • Phase 1 construction works at HMW continue to progress with first production targeted for H1 2026

PERTH, AU / ACCESS Newswire / January 28, 2026 / Galan Lithium Limited (ASX:GLN) (Galan or the Company) is pleased to announce it has received firm commitments from institutional and sophisticated investors, including major shareholder the Clean Elements Fund (Clean Elements) for a placement of A$40 million at an issue price of A$0.41 per share (Institutional Placement). Directors of the Company have also committed to subscribe for an additional $1 million on the same terms as the Institutional Placement, subject to shareholder approval (Director Placement).

Together with existing cash reserves, the proceeds from the equity raising will be used to complete Phase 1 construction activities, expand Phase 1 production capacity from 4 ktpa LCE to 5.2 ktpa LCE, undertake exploration activities at Greenbushes South and for working capital purposes.

First lithium chloride concentrate production to come out of a current inventory of circa 9,500 t LCE in evaporation ponds remains targeted for 1H 2026.

Galan's Managing Director, Juan Pablo (JP) Vargas de la Vega, commented:

"An accelerated recovery in lithium prices has provided Galan with an opportunity to expand HMW Phase 1 production capacity by 30%. Undertaking a Phase 1 expansion at this time will realise operational synergies for Galan, specifically saving on equipment and contractor mobilisation costs and cost savings in procurement.

"The equity raising has been very well supported with pricing at a premium to 5, 10 and 15 day VWAPs, which reflects that investors have recognised that Galan is well placed to take advantage of a higher lithium pricing environment, with first lithium chloride production targeted for the first half of 2026.

"On behalf of the Board of Directors, I would like to thank our shareholders for their ongoing support, which includes Clean Elements, and to welcome new high-caliber institutional investors from around the world to our register."

Details of the Equity Raising

Galan has received firm commitments to raise a total of $40 million under the Institutional Placement and an additional $1 million under the Director Placement (together the "Equity Raising"), at an issue price of $0.41 per share.

The Equity Raising will be undertaken in two tranches:

  • Tranche 1: Comprising the issue of approximately 86.6 million new fully paid ordinary share ("New Shares") to institutional, professional and sophisticated investors under Galan's placement capacity under ASX Listing Rules 7.1 and 7.1A.

  • Tranche 2: Comprising the issue of 13.4 million New Shares to Clean Elements and Directors of Galan, subject to shareholder approval under ASX Listing Rule 10.11 which will be sought at an Extraordinary General Meeting (EGM) to be held in Mid-March 2026. The date and details of the EGM will be communicated to shareholders on the ASX platform in due course.

The Equity Raising issue price of A$0.41 per New Share represents a:

  • 13% discount to the last closing price of A$0.470;

  • 2% premium to the 5-day VWAP of A$0.403;

  • 4% premium to the 10-day VWAP of A$0.395; and

  • 6% premium to the 15-day VWAP of A$0.386;

The New Shares will rank equally with existing Galan shares. The Institutional Placement is not underwritten.

Canaccord Genuity acted as Lead Manager and Bookrunner to the Placement.

Indicative Timetable 1,2

Event

Time / Date (2026)

Trading Halt

Tuesday, 27 January

Announcement of results of Equity Raising and trading halt lifted

Thursday, 29 January

DvP Settlement of New Shares issued under Tranche 1 of the Equity Raising

Tuesday, 3 February

Allotment of New Shares issued under Tranche 1 of the Equity Raising

Wednesday, 4 February

General Meeting to approve issue of New Shares under Tranche 2 of Equity Raising

Mid-March

Settlement of New Shares issued under Tranche 2 of the Equity Raising

Mid-March

Allotment of New Shares issued under Tranche 2 of the Equity Raising

Mid-March

  1. The Lead Manager and the Company reserve the right to vary these dates.

  2. All times are Australian Eastern Daylight Time unless otherwise indicated.

The Galan Board has authorised this release.

For further information contact:

COMPANY

MEDIA

Juan Pablo ("JP") Vargas de la Vega

Matt Worner

Managing Director

Vector Advisors

jp@galanlithium.com.au

mworner@vectoradvisors.au

+ 61 8 9214 2150

+61 429 522 924

SOURCE: Galan Lithium Limited



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/metals-and-mining/a40-million-institutional-placement-to-support-30-expansion-of-phase-1-hombre-mue-1131538

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.